Skip to main content

Table 3 p value and direction of upregulation of the seven metabolic pathways for tumorigenesis, Gleason grade, and lethal prostate cancer, according to the Gene Set Enrichment Analysis

From: The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study

Pathway (n genes)

Tumor tissue vs normal tissue (n = 202)

Gleason grade >8 tumors vs Gleason grade 2–7 tumors (n = 404; >8 = 106/2–7 = 298)

Lethal tumors vs. non-lethal tumors (n = 404; L = 113/NL = 291)

p value

Expression in tumor tissue

p value

Expression in high Gleason grade (>8) tumors

p value

Expression in lethal tumors

Fatty acid metabolism (n = 39)

0.70

↑

0.37

↓

0.14

↓

Glycolysis/gluconeogenesis (n = 62)

0.18

↑

0.75

↑

0.44

↓

Pentose phosphate (n = 27)

0.03

↑

0.21

↑

0.73

↑

Purine metabolism (n = 157)

6.0 × 10−3

↑

0.03

↑

0.07

↑

Pyrimidine metabolism (n = 96)

2.0 × 10−3

↑

3.0 × 10−3

↑

6.0 × 10−3

↑

Oxidative phosphorylation (n = 123)

<0.0001

↑

4.0 × 10−3

↑

6.0 × 10−3

↑

TCA (n = 30)

0.05

↑

0.64

↑

0.76

↑

  1. For the tumor vs. normal comparison matching is maintained and the GSEA-Preranked procedure is used with gene-based permutation p values; for the other two comparisons, standard GSEA is used with sample-based permutation p values